Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP7 | Q9UHL4 | 12/20 | 0.38 |
| ▸ | DPP8 | Q6V1X1 | 9/20 | 0.38 |
| ▸ | DPP4 | P27487 | 9/20 | 0.38 |
| ▸ | DPP9 | Q86TI2 | 3/20 | 0.33 |
| ▸ | GPR88 | Q9GZN0 | 1/20 | 0.32 |
| ▸ | IARS1 | P41252 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17549500 | 0.93 | DPP8 (0.35) | DPP7DPP8DPP4DPP9IARS1 | |
| Trifluoroacetic Acid SCHEMBL17537151 | 0.91 | DPP4 (0.36) | DPP7DPP8DPP4DPP9 | |
| Trifluoroacetic Acid SCHEMBL17537129 | 0.85 | DPP4 (0.33) | DPP7DPP4 | |
| Trifluoroacetic Acid SCHEMBL17537078 | 0.85 | DPP4 (0.35) | DPP7DPP4 | |
| Trifluoroacetic Acid SCHEMBL17537149 | 0.85 | TYR (0.37) | DPP7DPP4 | |
| Trifluoroacetic Acid SCHEMBL28110030 | 0.85 | TYR (0.37) | DPP7DPP4 | |
| Trifluoroacetic Acid SCHEMBL17537104 | 0.84 | DPP4 (0.34) | DPP7DPP4 | |
| Trifluoroacetic Acid SCHEMBL28110534 | 0.84 | DPP4 (0.34) | DPP7DPP4 | |
| SCHEMBL17549493 | 0.83 | SCN5A (0.34) | — | |
| SCHEMBL17549504 | 0.79 | TYR (0.40) | DPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9517988-B2 | Phenol derivative and preparation method and use in medicine thereof | SICHUAN HAISCO PHARMACEUTICAL CO., LTD. (CN) | 2016-12-13 | — | — | US | disclosed |
| EP-2995604-A1 | PHENOL DERIVATIVE AND PREPARATION METHOD AND USE IN MEDICINE THEREOF | Sichuan Haisco Pharmaceutical Co., Ltd. (CN) | 2016-03-16 | — | — | EP | disclosed |
| US-20160060197-A1 | PHENOL DERIVATIVE AND PREPARATION METHOD AND USE IN MEDICINE THEREOF | SICHUAN HAISCO PHARMACEUTICAL CO., LTD. (CN) | 2016-03-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160060197-A1 | PHENOL DERIVATIVE AND PREPARATION METHOD AND USE IN MEDICINE THEREOF | CYP2D6, CYP2B6, CYP2A6 | DPP7 369/4885DPP8 835/4885DPP4 427/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.